Veraxa Biotech shareholders approved all proposals at extraordinary general meeting

• Veraxa held an extraordinary general meeting today.
• Shareholders adopted all board proposals.
• Approved amendments introduced conditional share capital for shareholder options and warrants.
• Approved changes also implemented a capital band running through Dec. 31, 2030.
• Approved revisions raised the maximum number of board directors to seven.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veraxa Biotech AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607241605OMX_____CNEWS_EN_GNW1001214328_en) on July 24, 2026, and is solely responsible for the information contained therein.